Purpose of review Giant cell arteritis is an important cause of blindness in patients over 60 years of age. We attempt to identify the important clinical aspects in the diagnosis and management of this disorder, so that treatment may be instituted expeditiously to limit visual loss. Recent findings In addition, we identify current areas of standards in the investigation and treatment of patients with suspected giant cell arteritis. Summary We review some newer treatment possibilities, based on recently proposed immunologic models of giant cell arteritis, that may lead to newer treatment modalities.
机构:
Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Auckland 1, New ZealandUniv Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Auckland 1, New Zealand
Chew, S. S. L.
Kerr, N. M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Auckland 1, New ZealandUniv Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Auckland 1, New Zealand
Kerr, N. M.
Danesh-Meyer, H. V.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Auckland 1, New ZealandUniv Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Auckland 1, New Zealand
机构:
Univ Missouri, Sch Med, Kansas City, MO 64108 USAKrieger Eye Inst Sinai, Baltimore, MD USA
Waldman, Steven D.
Waldman, Reid A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Missouri, Sch Med, Kansas City, MO 64108 USA
Univ Missouri, Sch Med, Free Eye Clin, Kansas City, MO 64108 USAKrieger Eye Inst Sinai, Baltimore, MD USA